• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MEDICAL MASTERS SERIES HEART VALSALVA AORTIC VALVES GRAFT; HEART-VALVE, MECHANICAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MEDICAL MASTERS SERIES HEART VALSALVA AORTIC VALVES GRAFT; HEART-VALVE, MECHANICAL Back to Search Results
Model Number 21VAVGJ-515
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Unspecified Infection (1930); Cardiac Tamponade (2226); Pericardial Effusion (3271)
Event Date 04/18/2023
Event Type  Injury  
Manufacturer Narrative
Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.
 
Event Description
Crd_992 - valved grafts pas.Eu0336 - 702 (r751347001, r751348701) it was reported that on (b)(6) 2023, a 21mm masters series¿ hp valved graft with gelweave valsalva technology (vavgj) was implanted in a patient.On (b)(6) 2023, the patient presented with hyperthermia due to infection.Medication was administered/adjusted.On (b)(6) 2023, transthoracic echocardiogram showed pericardium, localized pericardial effusion opposite the latero- and postero-ventricle wall, probably partitioned at 17 mm postero- ventricle, 17 mm latero-left ventricle, no repercussions on the cardiac chamber.A computerized tomography (ct) scan on (b)(6)2023, showed the appearance of an abundant pericardial effusion, measuring up to 27 mm in thickness opposite the lateral wall of the left ventricle.The pericardial effusion lead to cardiac tamponade medication was administered/adjusted.The patient was also treated with enoxaparin an anti-thrombotic regimen.On (b)(6) 2023, the patient presented for evacuation of the pericardial effusion by marfan with placement of 2 drains (latero lv and infero rv) and a thoracic drain.On (b)(6) 2023, tte and ct was performed and showed persistent pericardial effusion.The patient is stable.
 
Manufacturer Narrative
An event of pericardial effusion lead to cardiac tamponade was reported.A returned device assessment could not be performed as the device remains implanted and was not returned for analysis.Field noted that event was not caused by a abbott device.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed and the product met specifications.Based on the information received, the cause of the reported incident could not be conclusively determined.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MASTERS SERIES HEART VALSALVA AORTIC VALVES GRAFT
Type of Device
HEART-VALVE, MECHANICAL
Manufacturer (Section D)
ABBOTT MEDICAL
5050 nathan lane n
plymouth MN 55442
Manufacturer (Section G)
ST. JUDE MEDICAL PUERTO RICO, INC. REG#2648612
20 b st caguas west park
caguas 00725
*   00725
Manufacturer Contact
karen krouse
5050 nathan lane n
plymouth, MN 55442
6517565400
MDR Report Key16942902
MDR Text Key315355975
Report Number2135147-2023-02139
Device Sequence Number1
Product Code LWQ
UDI-Device Identifier05414734009478
UDI-Public05414734009478
Combination Product (y/n)N
Reporter Country CodeFR
PMA/PMN Number
P810002
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Study,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 05/23/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/16/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number21VAVGJ-515
Device Catalogue Number21VAVGJ-515
Device Lot Number31235429
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received05/17/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured12/17/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age56 YR
Patient SexFemale
Patient Weight65 KG
-
-